Plus Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement

Plus Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement No near-term Reverse Stock Split required to meet Bid Price Rule GlobeNewswire November 17, 2025 HOUSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform […]

Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access, affordability, domestic manufacturing and rare-disease

Atlantic International Corp. Achieves Strong YTD Performance Through Operational Efficiencies and Substantial Revenue Growth

Atlantic International Corp. Achieves Strong YTD Performance Through Operational Efficiencies and Substantial Revenue Growth GlobeNewswire November 17, 2025 ENGLEWOOD CLIFFS, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) — Atlantic International Corp. today announced continued operational momentum in its third-quarter 2025 results, reflecting a meaningful shift in the company's financial trajectory and a significant improvement in year-to-date

Edible Garden Recognized for Sustainability Leadership in NRG’s 6th Annual Excellence in Energy Awards

Edible Garden Recognized for Sustainability Leadership in NRG's 6th Annual Excellence in Energy Awards GlobeNewswire November 17, 2025 Earns Silver Award for Its Commitment to Environmentally Responsible Operations, Zero-Waste Initiatives, and Innovative CEA Technologies Highlights Company's Progress in Advancing Energy Efficient Agriculture and Strengthening Its Position as a Sustainability Leader in the CEA Sector BELVIDERE,

Applied Materials to Participate at UBS Global Technology and AI Conference

Applied Materials to Participate at UBS Global Technology and AI Conference GlobeNewswire November 17, 2025 SANTA CLARA, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that Brice Hill, Senior Vice President and CFO, will participate in a fireside chat at the UBS Global Technology and AI Conference on Tuesday, Dec. 2

Revival Gold Intersects 1.4 g/T Oxide Gold Over 44.2 Meters in Shallow Drilling and Extends Mineralization at Mercur

Revival Gold Intersects 1.4 g/T Oxide Gold Over 44.2 Meters in Shallow Drilling and Extends Mineralization at Mercur GlobeNewswire November 17, 2025 TORONTO, Nov. 17, 2025 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to provide further results from ongoing drilling at the Company's Mercur Gold

Codere Online Reports Financial Results for the Third Quarter 2025

Codere Online Reports Financial Results for the Third Quarter 2025 GlobeNewswire November 17, 2025 Total revenue was EUR47.7 mm in Q3 2025, while net gaming revenue1 was EUR51.6 mm in the period, flat versus Q3 2024 (3% in constant currency terms). Mexico revenue was EUR24.0 mm in Q3 2025, while net gaming revenue was EUR26.8

First American Uranium Inc. Announces Effective Date for Name Change

First American Uranium Inc. Announces Effective Date for Name Change GlobeNewswire November 17, 2025 Vancouver, BC, Nov. 17, 2025 (GLOBE NEWSWIRE) — First American Uranium Inc. (CSE: NIOB) (FSE: IOR) (OTCQB: NIOMF) (“First American”, or the “Company”) is pleased to announce, further to its news release of November 3, 2025, it will change its name

BrainsWay Launches First Clinical Trial of Deep TMS 360(TM) System for Alcohol Use Disorder

BrainsWay Launches First Clinical Trial of Deep TMS 360(TM) System for Alcohol Use Disorder Multicenter, randomized, controlled study will evaluate Company's next-generation multichannel TMS technology in reducing heavy drinking and cravings GlobeNewswire November 17, 2025 BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),

Enza Zaden and Pairwise Join Forces to Drive Sustainable Innovation in Vegetable Breeding

Enkhuizen, the Netherlands, and Durham, North Carolina, Nov. 17, 2025 (GLOBE NEWSWIRE) — Enza Zaden, a global leader in vegetable breeding that develops and supplies innovative vegetable seeds for growers worldwide, today announced a strategic agreement to license Pairwise's Fulcrum(R) Platform, a suite of precision plant breeding tools. “At Enza Zaden, our mission is to grant people everywhere access to healthy vegetables by developing

Scroll to Top